{"id":1593,"date":"2020-12-09T15:14:40","date_gmt":"2020-12-09T15:14:40","guid":{"rendered":"https:\/\/sfj-pharma.com\/?p=1593"},"modified":"2021-02-10T18:38:17","modified_gmt":"2021-02-10T18:38:17","slug":"phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452","status":"publish","type":"post","link":"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/","title":{"rendered":"PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals\u00ae for PB2452"},"content":{"rendered":"<p>[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;grid&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221; z_index=&#8221;&#8221;][vc_column][vc_column_text]<em>PhaseBio to receive up to\u00a0$120 million\u00a0in development funding<\/em><\/p>\n<p><em>PhaseBio retains exclusive worldwide commercial rights to PB2452<\/em><\/p>\n<p>MALVERN, Pa.\u00a0and\u00a0SAN DIEGO,\u00a0Jan. 10, 2020\u00a0(GLOBE NEWSWIRE) \u2014\u00a0PhaseBio Pharmaceuticals, Inc.\u00a0(Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced a financing and co-development collaboration with\u00a0SFJ Pharmaceuticals\u00a0to support the development of PB2452, a reversal agent for the antiplatelet therapy ticagrelor.\u00a0SFJ Pharmaceuticals\u00a0is a global drug development company backed by Blackstone Life Sciences and Abingworth.<\/p>\n<p>The collaboration between SFJ and PhaseBio will support the global development of PB2452, which is designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations. Under the terms of the agreement, SFJ has agreed to fund up to\u00a0$120 million\u00a0to support the clinical development of PB2452 and to assume a central role in global clinical development and regulatory activities for PB2452 outside\u00a0the United States. SFJ will fund up to\u00a0$90 million\u00a0of development expenses through the end of 2021 and up to an additional\u00a0$30 million\u00a0based on PhaseBio meeting specific, pre-defined clinical milestones for PB2452.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MALVERN, Pa.\u00a0and\u00a0SAN DIEGO,\u00a0Jan. 10, 2020\u00a0(GLOBE NEWSWIRE) \u2014\u00a0PhaseBio Pharmaceuticals, Inc.\u00a0(Nasdaq: PHAS), a clinical-stage<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[103],"tags":[],"class_list":["post-1593","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals\u00ae for PB2452 - SFJ Pharmaceuticals<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals\u00ae for PB2452 - SFJ Pharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa.\u00a0and\u00a0SAN DIEGO,\u00a0Jan. 10, 2020\u00a0(GLOBE NEWSWIRE) \u2014\u00a0PhaseBio Pharmaceuticals, Inc.\u00a0(Nasdaq: PHAS), a clinical-stage\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/\" \/>\n<meta property=\"og:site_name\" content=\"SFJ Pharmaceuticals\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-09T15:14:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-02-10T18:38:17+00:00\" \/>\n<meta name=\"author\" content=\"khateam\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"khateam\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/\"},\"author\":{\"name\":\"khateam\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#\/schema\/person\/049145e1c21636813c9d02a662ef41cc\"},\"headline\":\"PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals\u00ae for PB2452\",\"datePublished\":\"2020-12-09T15:14:40+00:00\",\"dateModified\":\"2021-02-10T18:38:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/\"},\"wordCount\":237,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/\",\"url\":\"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/\",\"name\":\"PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals\u00ae for PB2452 - SFJ Pharmaceuticals\",\"isPartOf\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/#website\"},\"datePublished\":\"2020-12-09T15:14:40+00:00\",\"dateModified\":\"2021-02-10T18:38:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sfj-pharma.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals\u00ae for PB2452\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#website\",\"url\":\"https:\/\/www.sfj-pharma.com\/\",\"name\":\"SFJ Pharmaceuticals\",\"description\":\"Resources for Accelerated Clinical Development\",\"publisher\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sfj-pharma.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#organization\",\"name\":\"SFJ Pharmaceuticals\",\"url\":\"https:\/\/www.sfj-pharma.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/secureservercdn.net\/198.71.233.213\/c59.835.myftpupload.com\/wp-content\/uploads\/2020\/12\/SFJ-Logo-Final-RGB.png?time=1666279552\",\"contentUrl\":\"https:\/\/secureservercdn.net\/198.71.233.213\/c59.835.myftpupload.com\/wp-content\/uploads\/2020\/12\/SFJ-Logo-Final-RGB.png?time=1666279552\",\"width\":750,\"height\":205,\"caption\":\"SFJ Pharmaceuticals\"},\"image\":{\"@id\":\"https:\/\/www.sfj-pharma.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#\/schema\/person\/049145e1c21636813c9d02a662ef41cc\",\"name\":\"khateam\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sfj-pharma.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9bf77b4329fc605a71e83152d4944475?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9bf77b4329fc605a71e83152d4944475?s=96&d=mm&r=g\",\"caption\":\"khateam\"},\"sameAs\":[\"https:\/\/sfj-pharma.com\"],\"url\":\"https:\/\/www.sfj-pharma.com\/author\/khateam\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals\u00ae for PB2452 - SFJ Pharmaceuticals","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/","og_locale":"en_US","og_type":"article","og_title":"PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals\u00ae for PB2452 - SFJ Pharmaceuticals","og_description":"MALVERN, Pa.\u00a0and\u00a0SAN DIEGO,\u00a0Jan. 10, 2020\u00a0(GLOBE NEWSWIRE) \u2014\u00a0PhaseBio Pharmaceuticals, Inc.\u00a0(Nasdaq: PHAS), a clinical-stage","og_url":"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/","og_site_name":"SFJ Pharmaceuticals","article_published_time":"2020-12-09T15:14:40+00:00","article_modified_time":"2021-02-10T18:38:17+00:00","author":"khateam","twitter_card":"summary_large_image","twitter_misc":{"Written by":"khateam","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/#article","isPartOf":{"@id":"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/"},"author":{"name":"khateam","@id":"https:\/\/www.sfj-pharma.com\/#\/schema\/person\/049145e1c21636813c9d02a662ef41cc"},"headline":"PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals\u00ae for PB2452","datePublished":"2020-12-09T15:14:40+00:00","dateModified":"2021-02-10T18:38:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/"},"wordCount":237,"commentCount":0,"publisher":{"@id":"https:\/\/www.sfj-pharma.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/","url":"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/","name":"PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals\u00ae for PB2452 - SFJ Pharmaceuticals","isPartOf":{"@id":"https:\/\/www.sfj-pharma.com\/#website"},"datePublished":"2020-12-09T15:14:40+00:00","dateModified":"2021-02-10T18:38:17+00:00","breadcrumb":{"@id":"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sfj-pharma.com\/phasebio-announces-financing-and-co-development-collaboration-with-sfj-pharmaceuticals-for-pb2452\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sfj-pharma.com\/"},{"@type":"ListItem","position":2,"name":"PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals\u00ae for PB2452"}]},{"@type":"WebSite","@id":"https:\/\/www.sfj-pharma.com\/#website","url":"https:\/\/www.sfj-pharma.com\/","name":"SFJ Pharmaceuticals","description":"Resources for Accelerated Clinical Development","publisher":{"@id":"https:\/\/www.sfj-pharma.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sfj-pharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.sfj-pharma.com\/#organization","name":"SFJ Pharmaceuticals","url":"https:\/\/www.sfj-pharma.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sfj-pharma.com\/#\/schema\/logo\/image\/","url":"https:\/\/secureservercdn.net\/198.71.233.213\/c59.835.myftpupload.com\/wp-content\/uploads\/2020\/12\/SFJ-Logo-Final-RGB.png?time=1666279552","contentUrl":"https:\/\/secureservercdn.net\/198.71.233.213\/c59.835.myftpupload.com\/wp-content\/uploads\/2020\/12\/SFJ-Logo-Final-RGB.png?time=1666279552","width":750,"height":205,"caption":"SFJ Pharmaceuticals"},"image":{"@id":"https:\/\/www.sfj-pharma.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.sfj-pharma.com\/#\/schema\/person\/049145e1c21636813c9d02a662ef41cc","name":"khateam","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sfj-pharma.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9bf77b4329fc605a71e83152d4944475?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9bf77b4329fc605a71e83152d4944475?s=96&d=mm&r=g","caption":"khateam"},"sameAs":["https:\/\/sfj-pharma.com"],"url":"https:\/\/www.sfj-pharma.com\/author\/khateam\/"}]}},"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"khateam","author_link":"https:\/\/www.sfj-pharma.com\/author\/khateam\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.sfj-pharma.com\/category\/news\/\" rel=\"category tag\">News<\/a>","rttpg_excerpt":"MALVERN, Pa.\u00a0and\u00a0SAN DIEGO,\u00a0Jan. 10, 2020\u00a0(GLOBE NEWSWIRE) \u2014\u00a0PhaseBio Pharmaceuticals, Inc.\u00a0(Nasdaq: PHAS), a clinical-stage","_links":{"self":[{"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/posts\/1593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/comments?post=1593"}],"version-history":[{"count":2,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/posts\/1593\/revisions"}],"predecessor-version":[{"id":1848,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/posts\/1593\/revisions\/1848"}],"wp:attachment":[{"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/media?parent=1593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/categories?post=1593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sfj-pharma.com\/wp-json\/wp\/v2\/tags?post=1593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}